N6-Methyladenosine RNA Methylation: A Key Regulator in Male Reproductive Disorders and Urological Cancers
The World Journal of Men's Health · 2026 · 44 (3) · 533
DOI: 10.5534/wjmh.250125 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The World Journal of Men's Health, 2026. Verfasst von Xiaopeng Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Xinglin Scholar Research Premotion Project of Chengdu University of TCM, National Natural Science Foundation of China.
Abstract (Originalsprache)
In the field of male health, disorders of the reproductive and urological systems present significant challenges. The global increase in male infertility, primarily attributed to environmental and lifestyle factors, along with the high incidence of urological cancers, not only places a significant socio-economic burden but also emphasizes the urgent need for in-depth research. Epigenetic modifications, especially N6-methyladenosine (m6A) methylation, are of great importance in these conditions. m6A, which is regulated by specific "writer", "eraser", and "reader" proteins, has an impact on various RNA-related processes. This review summarizes the regulatory functions of m6A in male reproductive health and urological cancers. In male reproduction, it explores how m6A affects somatic cell functions, steroidogenesis, and the blood-testis barrier. It also delves into its role in diabetic erectile dysfunction and benign prostatic hyperplasia. In urological cancers, the review examines m6A's influence on metabolic reprogramming, programmed cell death, and tumor immunity. Furthermore, this review discusses the potential of targeting m6A as a therapeutic approach for these conditions. By integrating recent research findings, it offers new perspectives on the role of m6A in male reproductive and urological disorders, laying a foundation for future research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Reproductive Medicine Center, Chengdu Fifth People's Hospital, The Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. yuanrenbin123@163.com.
- School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China. yangfang@cdutcm.edu.cn.
ORCID-Profile: Xiaopeng Huang, Xiaoya Li, Xiucheng Lan, Meijing Wang, Jingyi Zhang, Liang Dong, Junjun Li, Xujun Yu, Renbin Yuan, Fang Yang
Förderung
- Xinglin Scholar Research Premotion Project of Chengdu University of TCM
- National Natural Science Foundation of China
Zitieren
APA
Huang, X., Li, X., Lan, X., Wang, M., Zhang, J., Dong, L., Li, J., Yu, X., Yuan, R., & Yang, F. (2026). N6-Methyladenosine RNA Methylation: A Key Regulator in Male Reproductive Disorders and Urological Cancers. The World Journal of Men's Health, 44(3), 533. https://doi.org/10.5534/wjmh.250125
Vancouver
Huang X, Li X, Lan X, Wang M, Zhang J, Dong L, et al. N6-Methyladenosine RNA Methylation: A Key Regulator in Male Reproductive Disorders and Urological Cancers. The World Journal of Men's Health. 2026;44(3):533. doi:10.5534/wjmh.250125
BibTeX
@article{Huang2026,
author = {Huang, Xiaopeng and Li, Xiaoya and Lan, Xiucheng and Wang, Meijing and Zhang, Jingyi and Dong, Liang and Li, Junjun and Yu, Xujun and Yuan, Renbin and Yang, Fang},
title = {N6-Methyladenosine RNA Methylation: A Key Regulator in Male Reproductive Disorders and Urological Cancers},
journal = {The World Journal of Men's Health},
year = {2026},
volume = {44},
number = {3},
pages = {533},
doi = {10.5534/wjmh.250125}
}
EUVIMED